# FDA Inspection 1204113 - Fayz A. Hudefi, M.D. - April 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/fayz-a-hudefi-md/0f9eb30e-0a46-4173-afa9-296053a02d79
Source feed: FDA_Inspections

> FDA inspection 1204113 of Fayz A. Hudefi, M.D., April 21, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204113
- Company Name: Fayz A. Hudefi, M.D.
- Inspection Date: 2023-04-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1249620 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/fayz-a-hudefi-md/90a08b74-1c3e-4b32-a605-553dc5b98901)
- FDA Inspection 1131413 - 2020-09-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/fayz-a-hudefi-md/01861255-1c5d-4ec4-9bf9-f60e5ecfe54d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c